Related Experiment Video
Updated: Mar 27, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.1K
Correction: PDZK1 inhibits MRP2-mediated oxaliplatin chemosensitivity in hepatocellular carcinoma
Zeqi Duan1, Jinyu Li2,3, Chao Ren4
1First Clinical Medical College, Shanxi Medical University, Taiyuan, 030001, Shanxi Province, People's Republic of China.
Scientific Reports
|March 25, 2026
Abstract
No abstract available in PubMed .
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.3K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.6K